References
- Abbas A K, Murphy K M, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–793, [PUBMED], [INFOTRIEVE]
- Björksten B. The environment and sensitization to allergens in early childhood. Pediatr Allergy Immunol 1997; 8(10 suppl)32–39
- Bousquet J, Lockey R F, Malling H J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53(suppl)1–42, [CSA]
- Busse W, Corren J, Lanier B Q, McAlary M, Fowler‐Taylor A, Cioppa G D, van As A, Gupta N. Omalizumab, anti‐IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108(2)184–190, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Barnes P J. Cytokine‐directed therapies for asthma. J Allergy Clin Immunol 2001; 108(2 Suppl)S72–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Santeliz J V, Van Nest G, Traquina P, Larsen E, Wills‐Karp M. MAmb a 1‐linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002; 109(3)455–462, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kimball E S, Schneider C R, Fisher M C, Clark M C. Levamisole causes differential cytokine expression by elicited mouse peritoneal macrophages. J Leukoc Biol 1992; 52: 349–356, [PUBMED], [INFOTRIEVE], [CSA]
- Redondo J M, Lopez‐Guerrero J A, Fresno M. Potentiation of interleukin‐2 activity by levamisole and imidazole. Immunol Lett 1987; 14: 111–116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Szeto C, Gillespie K M, Mathieson P W. Levamisole induces interleukin‐18 and shifts type 1/type 2 cytokine balance. Immunology 2000; 100: 217–224, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sargent D J, Goldberg R M, Jacobson S D, Macdonald J S, Labiance R, Haller D G, Shepherd L E, Seitz J F, Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345: 1091–1097, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Holcombe R F, Milovanovic T, Stewart R M, Brodhag T M. Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints. Cancer Detect Prev 2001; 25: 183–191, [PUBMED], [INFOTRIEVE]
- Prakash M S, Rao V M, Reddy V. Effect of levamisole on the immune status of malnourished children. J Trop Pediatr 1998; 44: 165–166, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Meadow S R, Sarsfield J K. Steroid‐responsive nephrotic syndrome and allergy: clinical studies. Arch Dis Child 1981; 56: 509–516, [PUBMED], [INFOTRIEVE]
- Schulte‐Wissermann H, Gortz W, Straub E. IgE in patients with glomerulonephritis and minimal change nephrotic syndrome. Eur J Pediatr 1979; 131: 105–111, [CROSSREF]
- Drachman R, Schlesinger M, Alon U, Mor J, Etzioni A, Shapira H, Ohali M, Drukker. Immunoregulation with levamisole in children with frequently relapsing steroid responsive nephrotic syndrome. Acta Paediatr Scand 1988; 77: 721–726, [PUBMED], [INFOTRIEVE]
- British Association for Pediatric Nephrology. Levamisole for corticosteroid‐dependent nephrotic syndrome in childhood. Lancet 1991; 337: 1555–1557
- Dayal U, Dayal A K, Shastry J CM, Raghupaty P. Use of levamisole in maintaining remission in steroid sensitive nephrotic syndrome in children. 1994; 66: 408–412
- Tsitoura D C, Blumenthal R L, Berry G, DeKruyff R, Umetsu D T. Mechanisms of preventing allergen induced airways hyperreactivity: role of tolerance and immune deviation. J Allergy Clin Immunol 2000; 106: 239–246, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yoshimoto T, Okamura H, Tagawa Y‐I, Iwakura Y, Nakanishi K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon‐gamma production from activated B cells. Proc Natl Acad Sci 1997; 94: 3948–3953, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]